279 related articles for article (PubMed ID: 38256070)
21. TREM2
Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
[TBL] [Abstract][Full Text] [Related]
22. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
23. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
Song Z; Wang X; Liu X; Luo Y; Qiu J; Yin A; Liu Y; Yi H; Xiao Z; Li A
Biochem Pharmacol; 2023 Jul; 213():115612. PubMed ID: 37209858
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
Bao D; Zhao J; Zhou X; Yang Q; Chen Y; Zhu J; Yuan P; Yang J; Qin T; Wan S; Xing J
Oncogene; 2019 Jun; 38(25):5007-5020. PubMed ID: 30894684
[TBL] [Abstract][Full Text] [Related]
25. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
[TBL] [Abstract][Full Text] [Related]
26. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
[TBL] [Abstract][Full Text] [Related]
27. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB.
Yu H; Pan J; Zheng S; Cai D; Luo A; Xia Z; Huang J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902024
[TBL] [Abstract][Full Text] [Related]
29. Metabolism drives macrophage heterogeneity in the tumor microenvironment.
Li S; Yu J; Huber A; Kryczek I; Wang Z; Jiang L; Li X; Du W; Li G; Wei S; Vatan L; Szeliga W; Chinnaiyan AM; Green MD; Cieslik M; Zou W
Cell Rep; 2022 Apr; 39(1):110609. PubMed ID: 35385733
[TBL] [Abstract][Full Text] [Related]
30. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma.
Xiang L; Piao L; Wang D; Qi LF
Front Immunol; 2022; 13():974241. PubMed ID: 36544774
[TBL] [Abstract][Full Text] [Related]
32. A theranostic metallodrug modulates immunovascular crosstalk to combat immunosuppressive liver cancer.
Luo Y; Wang J; Xu L; Du Q; Fang N; Wu H; Liu F; Hu L; Xu J; Hou J; Zhong Y; Liu Y; Wang Z; Ran H; Guo D
Acta Biomater; 2022 Dec; 154():478-496. PubMed ID: 36280029
[TBL] [Abstract][Full Text] [Related]
33. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
[TBL] [Abstract][Full Text] [Related]
34. Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation.
Papadakos SP; Machairas N; Stergiou IE; Arvanitakis K; Germanidis G; Frampton AE; Theocharis S
Cells; 2023 Aug; 12(16):. PubMed ID: 37626849
[TBL] [Abstract][Full Text] [Related]
35. MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma.
Fei Y; Wang Z; Huang M; Wu X; Hu F; Zhu J; Yu Y; Shen H; Wu Y; Xie G; Zhou Z
J Viral Hepat; 2023 May; 30(5):417-426. PubMed ID: 36704832
[TBL] [Abstract][Full Text] [Related]
36. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
37. Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.
Dubey S; Ghosh S; Goswami D; Ghatak D; De R
Biochem Pharmacol; 2023 Feb; 208():115369. PubMed ID: 36481347
[TBL] [Abstract][Full Text] [Related]
38. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.
Lian J; Liang Y; Zhang H; Lan M; Ye Z; Lin B; Qiu X; Zeng J
Front Immunol; 2022; 13():912279. PubMed ID: 36119047
[TBL] [Abstract][Full Text] [Related]
39. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
40. Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8
Chang Z; Zhang Q; Hu Q; Liu Y; Zhang L; Liu R
Biomed Pharmacother; 2022 Oct; 154():113543. PubMed ID: 36057223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
